RPWA
MRNA icon

Regent Peak Wealth Advisors’s Moderna MRNA Stock Holding History

Regent Peak Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,387
Closed -$534K – 171
2021
Q3 		$534K Buy
1,387
+252
+22% +$92.9K 0.15% 87
2021
Q2 		$401K Buy
+1,135
New +$203K 0.11% 106
2021
Q1 		– Sell
-1,123
Closed -$117K – 661
2020
Q4 		$117K Buy
+1,123
New +$114K 0.04% 192

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Regent Peak Wealth Advisors's MRNA Position: Q4 2021 in Review

Regent Peak Wealth Advisors sold out of Moderna (MRNA) in Q4 2021, closing a stake of 1,387 shares — an estimated $534K sold.

Regent Peak Wealth Advisors first reported a position in MRNA in Q4 2020 and held it in 3 quarters. The position peaked at $534K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Regent Peak Wealth Advisors reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Regent Peak Wealth Advisors sold 1,387 Moderna shares in Q4 2021, an estimated $534K.
  • Regent Peak Wealth Advisors first reported a position in Moderna in Q4 2020 and held it in 3 quarters.
  • Regent Peak Wealth Advisors's Moderna position peaked at $534K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Regent Peak Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.